Universal Health Realty Income Trust — 2023 Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2023; filed February 27, 2024. The filing is an annual report, although the request metadata references 2023 Q4.
Business Context
Universal Health Realty Income Trust is a Maryland healthcare-focused REIT. As of February 27, 2024, it had 76 investments or commitments across 21 states, including six hospitals, 60 medical office buildings, four free-standing emergency departments, four childcare centers, one vacant specialty facility and one vacant land investment.
Universal Health Services, Inc. and its subsidiaries remain the principal related-party tenant and provide the Trust’s advisory services. UHS-related tenants generated approximately 41% of consolidated revenue in 2023, and UHS subsidiaries leased all six hospital facilities owned by the Trust.
2023 Financial and Operating Metrics
| Metric | 2023 | 2022 | Change |
|---|---|---|---|
| Revenue | $95.6 million | $90.6 million | +$5.0 million, or 5.5% |
| Net income | $15.4 million | $21.1 million | -$5.7 million |
| Diluted earnings per share | $1.11 | $1.53 | -$0.42 |
| Funds from operations | $44.6 million | $48.8 million | -$4.3 million |
| FFO per diluted share | $3.23 | $3.54 | -$0.31 |
| Cash flow from operations | $42.9 million | $46.8 million | -$3.9 million |
| Dividends paid | $39.8 million | $39.2 million | +$0.6 million |
Revenue growth primarily reflected higher rental income from the portfolio, including the Reno medical office building and the McAllen Doctor’s Center acquisition. Net income declined primarily because net interest expense increased by $6.2 million. The filing does not provide a consolidated operating margin.
At December 31, 2023, total assets were $596.4 million, net real estate investments were $443.8 million, the UHS financing receivable was $83.3 million, cash and cash equivalents were $8.2 million, and total equity was $200.9 million.
Debt, Liquidity and Capital Allocation
- The revolving credit facility had a $375 million commitment, $326.6 million drawn, $3.1 million of letters of credit outstanding and $45.3 million of available capacity at year-end.
- The revolving facility matures July 2, 2025, subject to extension options, and bears interest based on adjusted term SOFR or the Base Rate plus a leverage-based margin. The applicable SOFR margin was 1.20% at year-end.
- Non-recourse mortgage debt was $32.9 million, compared with $44.7 million at December 31, 2022. A $12.3 million mortgage is scheduled to mature in April 2024.
- Total consolidated debt, including revolving borrowings and mortgages, was approximately $359.7 million. Estimated 2025 debt maturities include $326.6 million of revolving borrowings scheduled to mature in July 2025.
- Management reported compliance with all credit agreement covenants. Year-end total leverage was 44.5% versus a maximum of 60%, and fixed-charge coverage was 3.1x versus a minimum of 1.50x.
- Capital expenditures and acquisitions used $19.1 million of investing cash flow. The Trust spent $15.6 million on real estate additions, $7.6 million to acquire McAllen Doctor’s Center and $4.1 million on investments in unconsolidated LLCs.
- The Trust paid $39.8 million of dividends, or $2.88 per share. Operating cash flow exceeded dividends paid by approximately $3.2 million.
Material Changes Versus 2022
- Revenue increased 5.5%, but higher borrowing costs materially reduced profitability. Average revolving debt increased to $309.3 million from $277.9 million, while the average effective borrowing rate increased to 4.8% from 2.9%, including fees and interest-rate hedges.
- Net interest expense increased to $16.9 million from $10.8 million. Interest expense on the revolving facility increased substantially, partly offset by $5.8 million of net interest receipts from interest-rate swaps.
- The Trust completed the $7.6 million acquisition of McAllen Doctor’s Center, a 79,500-square-foot MOB fully leased to a UHS subsidiary through August 2035, with an initial annual base rent of approximately $624,000.
- Sierra Medical Plaza I in Reno was substantially completed during the first quarter of 2023. Estimated total cost was approximately $35 million, of which approximately $29 million had been incurred by year-end. Occupancy was 44% in 2023.
- The vacant Corpus Christi specialty facility was sold in December 2023 for approximately $3.9 million net proceeds, generating a $232,000 loss.
- Demolition of the former Chicago specialty hospital was completed. The Trust incurred approximately $1.1 million of demolition expense in 2023 and continues to market the resulting vacant land.
- Medical office building leasing activity increased to 73 new or renewed leases covering approximately 22% of aggregate rentable square feet, compared with 46 leases covering approximately 13% in 2022. Renewal rates increased approximately 4% in 2023 versus 2% in 2022.
- The credit facility was amended in May 2023 to replace LIBOR with adjusted term SOFR. The Trust also entered into a new $25 million interest-rate swap effective December 1, 2023.
Outlook, Commentary and Key Risks
Management believes operating cash flow, cash, available revolver capacity and access to capital markets are sufficient to fund operating, investing and financing requirements for the next twelve months, including REIT distribution requirements. No formal earnings or FFO guidance was provided.
- UHS concentration and related-party dependence: UHS-related tenants represented approximately 41% of 2023 consolidated revenue. UHS also owns 5.7% of the Trust, provides advisory and executive personnel, and has renewal, purchase and rights-of-first-refusal provisions on certain properties.
- Lease rollover: Two hospital leases expiring in 2026 represent approximately $15.1 million of annual rentals, or 14% of annual rentals in the filing’s expiration schedule. Nonrenewal, purchase-option exercises or less favorable replacement leases could reduce revenue and dividends.
- Interest-rate and refinancing risk: The Trust has substantial variable-rate borrowings, with $326.6 million due under the revolver in 2025. A 1% change in applicable variable interest rates would affect net income by approximately $1.6 million after giving effect to interest-rate swaps.
- Healthcare reimbursement and regulation: Tenant performance depends on Medicare, Medicaid and commercial payer reimbursement, licensing, certification and compliance with healthcare laws. Changes in reimbursement or regulatory enforcement could impair tenants’ ability to pay rent.
- Inflation and labor costs: Tenants continued to face elevated personnel, temporary labor, medical supply and construction costs, although some staffing and labor pressures moderated during 2023.
- Vacant assets: The Evansville specialty facility and Chicago land remain vacant and generate carrying costs. The Trust also has exposure to lease-up, tenant improvement and redevelopment costs.
- Cybersecurity: The Trust relies on UHS and third-party property managers for certain information technology systems. No cybersecurity incident was identified as having a material effect during 2023 or through the filing date.
- REIT status: The Trust must distribute at least 90% of annual REIT taxable income and maintain complex asset, income and ownership requirements. Failure to qualify could result in substantial tax liabilities and reduced cash available for distributions.
Investor Verification Checklist
- Verify the terms and refinancing plan for the $326.6 million revolver maturity in July 2025 and the $12.3 million mortgage maturity in April 2024.
- Assess UHS credit quality, lease renewal intentions and the effect of UHS purchase options on future rental income.
- Review the 2026 expiration of the McAllen Medical Center and Wellington Regional Medical Center leases and related annual rentals.
- Reconcile operating cash flow of $42.9 million with dividends paid of $39.8 million, including recurring capital expenditures and other funding needs.
- Track leasing progress, construction costs and tenant commitments at Sierra Medical Plaza I and the McAllen Doctor’s Center.
- Evaluate the carrying costs and potential recovery values of the vacant Evansville facility and Chicago land.
- Review UHS’s separate SEC filings for tenant operating performance, litigation, investigations and regulatory matters because UHS-related tenants account for a substantial portion of Trust revenue.